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Abstract Neonicotinoid insecticides, which act on nico-
tinic acetylcholine receptors (nAChRs) in a variety of
ways, have extremely low mammalian toxicity, yet the
molecular basis of such actions is poorly understood. To
elucidate the molecular basis for nAChR–neonicotinoid
interactions, a surrogate protein, acetylcholine binding
protein from Lymnaea stagnalis (Ls-AChBP) was
crystallized in complex with neonicotinoid insecticides
imidacloprid (IMI) or clothianidin (CTD). The crystal
structures suggested that the guanidine moiety of IMI and
CTD stacks with Tyr185, while the nitro group of IMI but
not of CTD makes a hydrogen bond with Gln55. IMI
showed higher binding afﬁnity for Ls-AChBP than that of
CTD, consistent with weaker CH–p interactions in the
Ls-AChBP–CTD complex than in the Ls-AChBP–IMI
complex and the lack of the nitro group-Gln55 hydrogen
bond in CTD. Yet, the NH at position 1 of CTD makes a
hydrogen bond with the backbone carbonyl of Trp143,
offering an explanation for the diverse actions of neoni-
cotinoids on nAChRs.
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Introduction
Nicotinic acetylcholine receptors (nAChRs) are ligand-
gated ion channels that mediate fast-acting excitatory
cholinergic neurotransmission in vertebrates and inverte-
brates. Each nAChR molecule consists of ﬁve subunits;
acetylcholine (ACh) binds at extracellular ligand-binding
domain (LBD) at the subunit interfaces, and a central,
cation-permeable ion channel opens transiently in response
to ACh and agonists (Karlin 2002; Sine and Engel 2006).
Each subunit possesses an N-terminal extracellular domain
with a conserved di-cysteine loop, four transmembrane
regions (TM1–TM4 of which TM2 provides most of the
channel-lining residues), and a large intracellular loop
between TM3 and TM4 (Karlin 2002). Usually, nAChRs
are made up of a and non-a subunits (Fig. 1a), the a
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LBD. The ACh binding site is located at the LBD inter-
faces and formed by loops A, B and C of the a subunit and
loops D, E and F which are normally located in non-a
subunit (Corringer et al. 2000; Karlin 2002; Lindstrom
2003). However, a7, a8 and a9 subunits can form func-
tional homo-pentamers (Couturier et al. 1990; Elgoyhen
et al. 1994; Gerzanich et al. 1994) (Fig. 1a), whereas a9
and a10 subunits form a hetero pentamers (Elgoyhen et al.
2001). When only a subunits are present, they donate not
only loops A–C, but also loops D–F.
Inmammals,nAChRsplaycentralrolesinneuromuscular
and inter-neuronal cholinergic neurotransmission. Muta-
tions in muscle nAChR subunits account for many cases of
congenitalmyastheniasyndrome(Engeletal.2003)andalso
multiplepterygium(Morganetal.2006),whereasmutations
in neuronal nAChR subunits (a4,b2) can produce epilepsies
(Aridon et al. 2006; Steinlein 2004). It has also been shown
that cholinergic neurotransmission is reduced in Alzhei-
mer’s (Marutle et al. 1999) and Parkinson’s diseases as well
as in schizophrenia (Woodruff-Pak and Gould 2002).
Further, in some cases of Alzheimer’s disease, loss of
nAChRshasbeenreported(Courtetal.2001).Thusthereisa
growing interest in nAChRs as potential drug targets
(Arneric et al. 2007; Dani and Bertrand 2007).
In the insect nervous system, where ACh is the primary
excitatory neurotransmitter, nAChRs are present at densi-
ties comparable to those in the electric organ of the electric
ﬁsh, Electrophorus electricus (Sattelle 1980), and several
classes of insecticides (cartap, bensultap, thiocyclam,
spinosad and neonicotinoids) target insect nAChRs
(Narahashi 2000; Raymond-Delpech et al. 2005; Millar and
Denholm 2007). Of these, neonicotinoids (Fig. 1a) are
increasingly used not only for controlling crop pests
worldwide, but also for animal health application such as
ﬂea and louse controls. Imidacloprid (IMI; Fig. 1b), the
ﬁrst insecticide with billion dollars per annum sales, is a
partial agonist of native (Deglise et al. 2002; Ihara et al.
2006; Tan et al. 2007) as well as of recombinant (Ihara
et al. 2003) nAChRs expressed in Xenopus laevis oocytes.
On the other hand, clothianidin (CTD; Fig. 1b) and its
analog evoke supra-maximal responses (with reference to
ACh responses) not only in the Drosophila Da2/chicken b2
hybrid nAChRs (Ihara et al. 2004) expressed in Xenopus
oocytes, but also in native Drosophila central cholinergic
neurons (Brown et al. 2006). Single channel recording has
shown that a CTD analog induces the opening of the
Drosophila nAChR channels at the largest conductance
state more frequently than ACh, offering a possible
explanation for its super-agonist action (Brown et al.
2006). Contrasting with these actions, some neonicotinoids
(Ihara et al. 2006; Salgado and Saar 2004), and
bis-neonicotinoids containing two neonicotinoid units
joined together by an alkyl chain (Ihara et al. 2007a),
antagonize the acetylcholine-induced responses of native
insect neurons.
Neonicotinoids show higher afﬁnity for insect nAChRs,
accounting, at least in part, for their selective toxicity to
insects over vertebrates (Matsuda et al. 2001, 2005;
Tomizawa and Casida 2005). Our studies using site-
directed mutagenesis combined with two-electrode volt-
age-clamp electrophysiology have shown that the X
residue in the YXCC motif of loop C (Shimomura et al.
2004), the region upstream of loop B (Shimomura et al.
2005) and basic residues in loop D (Shimomura et al.
2002, 2003, 2006) contribute to the high neonicotinoid
sensitivity of insect nAChRs (see Fig. 1c for loop
positions).
The acetylcholine binding protein (AChBP) from snail,
Lymnaea stagnalis (Ls-AChBP) was discovered in glial
cells as a water soluble protein modulating synaptic ACh
concentration (Smit et al. 2001), and the X-ray crystal
structure of the protein was described at the same time
(Brejc et al. 2001). Subsequently, X-ray crystal structures
of Ls-AChBP homologs from Aplysia californica (Ac-
AChBP) (Bourne et al. 2005) and Bulinus truncatus (Bt-
AChBP) (Celie et al. 2005b) were reported. Both Ls- and
Ac-AChBPs show similarities to the extracellular domain
of neuronal a7 nAChRs and form homopentamers in
solution (Smit et al. 2001). Notably, all the six regions
(loops A–F) that make up the ligand binding site are con-
served in AChBPs. Thus AChBPs are considered as
surrogates of the LBD in nAChRs and therefore have been
employed to elucidate the mechanism for interactions with
low molecular weight ligands as well as peptide toxin
antagonists (Bourne et al. 2005; Celie et al. 2004, 2005;
Dutertre et al. 2007; Hansen et al. 2005; Hansen and Taylor
2007; Ulens et al. 2006). Employing the crystal structures
of AChBPs, we have previously modeled LBDs in complex
with IMI to show that basic residues in loop D may interact
Fig. 1 Nicotinic acetylcholine receptors (nAChRs) and the acetyl-
choline binding protein (AChBP). a Schematic representation of
neuronal nicotinic acetylcholine receptors and acetylcholine binding
protein. b Chemical structures of natural nicotinic ligands and
neonicotinoids [imidacloprid (IMI) and clothianidin (CTD)] used in
this study. c Multiple sequence alignment of AChBP with the ligand
binding domain of nAChR subunits. Lymnaea stagnalis AChBP (Ls-
AChBP) and N-terminus LBD sequences of insect (species names are
colored magenta) and vertebrate (species names are colored black)
nAChRs are aligned using ClustalW2 program (Larkin et al. 2007)
with default parameters and the details are manually adjusted.
Secondary structure elements from the Ls-AchBP–IMI complex are
indicated above the multiple alignments. Amino acids involved in the
interactions with neonicotinoids are highlighted in bold with yellow
and cyan backgrounds in the principal (+)- and complementary (-)-
sides, respectively. Amino acid residue number from methionine for
each protein was indicated at the top of each sequence
c
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123electrostatically with the nitro group of neonicotinoids
(Shimomura et al. 2006). Yet, details of neonicotinoid–
nAChR interactions are poorly understood. Therefore, we
have crystallized the Ls-AChBP in complex with two
commercial neonicotinoids, IMI and CTD.
Materials and methods
Materials
Lymnaea stagnalis derived from the stocks of
Vrije Universeit (Amsterdam) was provided from
Professor Sakakibara at Tokai University. IMI and
CTD were gifts from BayerCropscience Co. in Japan.
1-(6-Bromopyridylmethyl)-2-nitroiminoimidazolidine
(bromine-substituted imidacloprid; Br-IMI) and N-(2-
bromo-thiazol-5-ylmethyl)-N0-methyl-N00-nitroguanidine
(bromine-substituted clothianidin; Br-CTD) were synthe-
sized according to the published methods (Maienﬁsch
et al. 2000; Nishiwaki et al. 2000).
Protein preparation
The cDNA of Ls-AChBP was ampliﬁed by RT-PCR from
L. stagnalis and was cloned into the pPICZa B vector
(Invitrogen) at the Pst I site, with an L1A mutation
introduced to facilitate cloning. The Ls-AChBPs were
expressed in yeast, Pichia pastris X-33 using EasySelect
Pichia Expression Kit (Invitrogen). Secreted proteins
were puriﬁed with Q-Sepharose column (GE Healthcare)
immediately following concentration and buffer-exchange
using Vivaﬂow200 (Zartorius), and then treated with
50 U/mg protein of peptide-N-glycosidase F (Wako Pure
Chemical Industries) at 37C for 24 h to remove the
glycosyl-chain at Asn67. The protein samples were sub-
sequently puriﬁed with Mono Q and Superdex 200
columns (GE Healthcare). Puriﬁed proteins were con-
ﬁrmed to be the samples of interest by N-terminal
sequencing and mass spectrometry. Puriﬁed proteins were
buffer-exchanged against 20 mM Tris–HCl buffer with
0.02% NaN3 (pH 8.0).
Evaluation of equilibrium binding of neonicotinoids
The equilibrium binding of neonicotinoids with Ls-AChBP
was determined by quenching of intrinsic tryptophan
ﬂuorescence. Ls-AChBP at 600 nM in binding site con-
centration in 20 mM Tris–HCl buffer with 0.02% NaN3
(pH 8.0) was incubated with each ligand at various con-
centrations on a 96-well plate. Ls-AChBP was excited at
280 nm, and emission intensity was recorded at 342 nm
using Varioskan microplate reader (Thermo Fisher
Scientiﬁc) at room temperature. Data were ﬁtted by non-
linear regression according to the following equation using
Prism Software version 4.03 (GraphPad Software):
DF
F0
¼
DFmax
F0
 
Kd þ½ X þ½ Protein  
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Kd þ½ X þ½ Protein  ðÞ
2   4  ½ X  ½ Protein 
q
2  ½ Protein 
;
where DF and DFmax represent quenching of ﬂuores-
cence at a ligand concentration X and maximum
quenching of ﬂuorescence at saturation, respectively. F0
and [Protein] are ﬂuorescence measured in the absence
of ligands and the concentration of Ls-AChBP,
respectively.
Crystallization and X-ray data collection
Puriﬁed Ls-AChBPs (6.0 mg/mL) were incubated with
0.5 mM neonicotinoids at 4C for 1 h prior to crystalli-
zation. Ls-AChBP-neonicotinoid complex crystals were
obtained by vapor diffusion method at 20C with 1:1
ratio of protein to reservoir solution containing 0.2 M Na
citrate pH 5.7, 15–22% PEG3350 and about 0.5 mM of
either IMI, CTD, Br-IMI or Br-CTD. The crystals were
ﬂash-cooled in liquid nitrogen after soaking into the
cryoprotectant solutions containing 0.2 M Na citrate pH
5.7, 25% PEG3350, 20% glycerol and about 0.5 mM of
each neonicotinoid. X-ray diffraction data sets were
collected at 90 K using either Bruker AXS DIP6040
detector at BL44XU (Yoshimura et al. 2007) or ADSC
QUANTUM 210 detector at BL44B2 (Adachi et al.
2001) beamlines in SPring-8, and processed with Mosﬂm
(Leslie 1992) or HKL2000 (Otwinowski and Minor
1997). In order to identify the positions of the sulfur
atom at the thiazole ring of CTD as well as the bromine
atom of Br-IMI and Br-CTD, anomalous data from the
crystals complexed with these neonicotinoids were col-
lected at wavelength of 1.75 A ˚ and 0.919 A ˚ (Table 1),
respectively.
Structure determination and reﬁnement
The structure of the IMI complex was solved by
molecular replacement with Phaser (McCoy 2007) using
the coordinates of an Ls-AChBP in complex with nico-
tine (PDB entry: 1UW6) (Celie et al. 2004) as a search
model. Subsequently, the reﬁned coordinates of the IMI
complex were used to solve the structure of the CTD
complex. Reﬁnements and manual model building were
performed with CNS version 1.2 (Bru ¨nger et al. 1998)
and Coot (Emsley and Cowtan 2004), respectively. The
non-crystallographic-symmetry restraints between the
74 Invert Neurosci (2008) 8:71–81
123subunits were initially applied for the reﬁnements and
removed at later steps. The details of data collection and
reﬁnement statistics are provided in Table 1. Figures are
generated by PyMOL (DeLano Scientiﬁc LLC), Bob-
script (Esnouf 1999) and Raster3D (Merritt and Bacon
1997).
Fig. 2 Overall view of crystal structure of Ls-AChBP complexed
with imidacloprid (IMI). The pentameric structure of Ls-AChBP is
viewed from the top (a) corresponding to an extracellular surface of
nAChRs and from the side (b). IMI molecules bound to Ls-AChBP
are shown in space-ﬁlling model, whereas carbons, nitrogens and
oxygens are colored green, blue and red, respectively. Two subunits,
A and B chains, are colored by pink and blue, respectively. c The
structure of A–B domain boundary of the Ls-AChBP complexed with
IMI (red) is compared with that of the Ls-AChBP complexed with
CTD (blue) and the apo form (light brown) complexed with 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) (PDB entry
code: 1UX2) (Celie et al. 2004). Ligands are presented by stick
models
Table 1 X-ray diffraction data collection and reﬁnement statistics for Ls-AChBP–neonicotinoid complexes
IMI CTD Br-IMI Br-CTD CTD (S ano)
a
Data collection
Beamline
b BL44XU BL44B2 BL44B2 BL44B2 BL44B2
Wavelength (A ˚) 0.900 0.919 0.919 0.919 1.75
Space group P65 P65 P65 P65 P65
Cell dimensions a, c (A ˚) 75.0, 351.0 74.6, 351.0 74.8, 350.9 74.5, 351.2 74.6, 351.3
Resolution (A ˚) 15.8–2.56 50.0–2.70 50.0–2.70 50.0–2.90 50.0–2.90
Rsym (%)
c, d 8.0 (41.3) 8.5 (38.9) 9.7 (34.1) 11.8 (34.1) 8.7 (39.5)
I/r
c 8.1 (1.7) 20.7 (4.0) 47.0 (10.7) 45.5 (10.9) 60.8 (9.32)
Completeness (%)
c 94.8 (96.7) 100 (100) 100 (100) 100 (100) 99.5 (96.2)
Redundancy
c 2.6 (2.6) 5.7 (5.7) 23.0 (23.3) 22.5 (23.2) 21.6 (20.5)
Reﬁnement
Resolution (A ˚) 15.8–2.58 50.0–2.70
No. of reﬂections 33031 30121
R/Rfree (%)
e 20.3/27.7 20.2/27.0
Bond length (A ˚)/angles (deg)
f 0.008/1.3 0.008/1.3
Average B factor 41.8 41.6
PDB accession code
g 2ZJU 2ZJV
See text for abbreviations of the neonicotinoid names
a Data set for detection of anomalous peaks at sulfur atoms
b All data sets were collected at SPring-8
c Values in parentheses refer to data in the highest resolution shells
d Rsym = R|I-\I[|/RI, where I is the observed intensity and\I[is the average intensity from multiple observations of the symmetry-related
reﬂections
e R = R||Fo|–| Fc|| / R|Fo|. Rfree is an R factor of the CNS reﬁnement evaluated for 5% of reﬂections that were excluded from the reﬁnement
f RMS deviations from ideal values were calculated
g The atomic coordinates and structure factors have been deposited in the Protein Data Bank
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Structure analysis
In this study, we have crystallized the Ls-AChBP in
complex with IMI and CTD to elucidate the mechanism
underpinning their selective and diverse actions on
nAChRs. Both complexes were crystallized in the same
space group with one pentamer in an asymmetric unit.
Ligand-omit and anomalous electron density maps clearly
indicated AChBP in the crystals bound neonicotinoids
(see Fig. 3a, b). The positions and orientations of the 2-
chloropyridine ring in IMI and 2-chloro-1,3-thiazole ring
in CTD were modeled to satisfy the observation of Br-
and S-anomalous peak positions. The X-ray crystal
structures of the Ls-AChBP complexed with IMI and
CTD were reﬁned at 2.58 and 2.70 A ˚ resolutions,
respectively (Table 1).
The neonicotinoid-bound Ls-AChBPs form the same
homopentameric structure (Fig. 2a, b) as those determined
for the 4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid (HEPES)-bound apo form (Brejc et al. 2001) and the
other ligand-bound forms (Celie et al. 2004, 2005; Hansen
et al. 2005; Ulens et al. 2006). Typically, each subunit has
a secondary structure composed of an N-terminal 12-
residue a-helix followed by b-strand-rich parts as shown
previously for other Ls-AChBPs. Root mean square dif-
ferences (rmsd) of Ca atoms between the IMI- or CTD-
complex and the nicotine-complex (Celie et al. 2004)
were observed as 0.975 and 0.758 A ˚, respectively. In two
structures determined in the present study, neonicotinoids
occupied all ﬁve ligand-binding sites that are formed
between the two adjacent subunits (Fig. 2a, b). The ne-
onicotinoids occupy broadly the same position as HEPES
and (-)-nicotine within the pocket formed by ‘‘A-F loop’’
regions. Although ‘‘loops A, B, D and E’’ are mainly
composed of b-strands and only loops C and F have no
canonical secondary structure, we use these designations
to facilitate comparison with previous studies on nAChRs
(Corringer et al. 2000; Matsuda et al. 2001, 2005). The
principal side [(+)-chain] of the ligand-binding site pos-
sesses residues from loops A, B and C which are located
in a subunits, whereas the complementary side [(-)-chain]
contains loops D, E and F, which are donated by non-a
subunits in a/non-a heteropentamers. Overall, the struc-
tures of the IMI and CTD complexes were very similar
with Ca rmsd of 0.597 A ˚. However, the loop C region has
a speciﬁc conformation in each complex. For example,
compared with the IMI complex, loop C of the CTD
complex takes a ‘‘closed conformation’’, showing
approximately 4 A ˚ shift of the positions of the Ca atoms
(Fig. 2c). The variations in loop C conformation were
often observed between different chains within the same
Ls-AChBP pentamer in complex with neonicotinoids (e.g.
subunits A and C of the CTD complex, data not shown).
Conformational change in loop C is evident when com-
paring structures with the apo form Ls-AChBP complexed
with HEPES (PDB entry code: 1UX2) (Fig. 2c). The
Thr155-Asp160 loop region of the (-)-chain upstream of
loop F also indicates a conformational change in the
ligand-binding site. These results suggest that induced-ﬁt
movement of loop regions is essential for recognition of
ligands including neonicotinoids. The detailed binding
interactions of neonicotinoids will be considered in rela-
tion to their key components, the aromatic ring and the
guanidine/related moieties.
Interactions with aromatic rings of insecticides
When complexed with Ls-AChBP, the pyridine ring of IMI
was buried deep in the binding site, interacting with loop E
segments from the (-)-chain (Fig. 3c). Recently, Tomizawa
et al. (2008) has reported that two azido-neonicotinoid
probes containing the photolabile group in the pyridine ring
labeled Tyr164 in loop F of the (-)-chain and Tyr192 in
Fig. 3 Electron density maps of bound ligands and their interactions
with the loop E region. The annealed Fo–Fc omit maps (blue) for
imidacloprid (IMI) (a) and clothianidin (CTD) (b) bound to the Ls-
AChBP are contoured at 4r and drawn with the ﬁnal models of the
native and non-Br-neonicotinoids. In addition, the anomalous maps of
bromine (purple) from the Br-neonicotinoid-complexes and sulfur
atoms (yellow) from the native-neonicotinoid-complexes for ligands,
which are contoured at 5 and 1.5r, respectively, are overlaid.
Interactions of the loop E region with pyridine moiety of IMI (c) and
thiazole moiety of CTD (d) are shown in the binding site of the Ls-
AChBP. In each ligand and amino acid, chlorine, nitrogen, oxygen
and sulfur atoms are colored purple, blue, red and yellow, respec-
tively. The hydrogen bonds are presented by orange broken lines
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123loop C of the (+)-chain in the Ls-AChBP. However, these
two distinct binding modes were not observed in our
models, neither in the IMI complex, nor in the CTD
complex of the Ls-AChBP. The nitrogen atom of the pyri-
dine ring forms a hydrogen bond with the amide group of
Met114 and the carbonyl group of Leu102 in loop E via a
water molecule, resembling the observations for both the
Ls-AChBP-nicotine complex (Celie et al. 2004) and Ac-
AChBP-epibatidine complex (Hansen et al. 2005).
The chlorine atom was located in the vicinity of a
hydrogen bond bridge between the backbone C = Oo f
Leu112 and the backbone amide NH of Arg104. As a
result, it made van der Waals contact the peptide back-
bones of these two amino acids. The aromatic ring of CTD
also contacts with the loop E segment in a manner similar
to IMI (Fig. 3d). The nitrogen atom of the thiazole ring of
CTD, in a similar fashion to the nitrogen atom of the
pyridine ring of IMI, formed hydrogen bond with the
backbone carbonyl of Leu102 and the backbone amide
group of Met114 via water molecule (Fig. 3d).
Nicotine, which is active not only on insect, but also on
vertebrate nAChRs, has also been shown to interact with the
backbone of loop E in a similar manner to neonicotinoids
(Celie et al. 2004). Therefore interactions with the backbone
are insufﬁcient to explain the selective actions of neoni-
cotinoids. On the other hand, Met114 in loop E was located
in the vicinity of the nitroimine group (Fig. 3c, d) which
plays a key role in selective insect nAChR–neonicotinoid
interactions (Ihara et al. 2003). Some insect a subunits
possess either basic or hydrogen bondable residues favor-
able for interactions with the nitro group such as those
corresponding to Met114 (Fig. 1c). Hence, if two adjacent a
subunits form a ligand-binding site, such residues may
contribute to the neonicotinoid sensitivity of insect
nAChRs.
Interactions with guanidine and related moieties
The crystal structures of the Ls-AChBP bound with nico-
tine or carbamylcholine (Celie et al. 2004) and Ac-AChBP
in the presence of epibatidine (Hansen et al. 2005), as well
as quantum chemical calculations (Cashin et al. 2005),
suggested that the protonated nitrogen atom in nicotinic
agonists undergoes cation–p interactions with Trp143 in
loop B. In line with this notion, it was earlier demonstrated
that the electron-deﬁcient guanidine moiety of neonicoti-
noids is likely to contact with Trp143 (Matsuda et al. 2005;
Tomizawa and Casida 2005). However, the guanidine
moiety of IMI and CTD was found to stack with the aro-
matic ring of Tyr185 in the crystal structures of CTD- as
well as IMI-Ls-AChBP complexes (Fig. 4a, d). Since
Tyr185 is conserved throughout vertebrate and invertebrate
nAChR a subunits (Fig. 1c), this residue itself is not
involved directly in determining the selective interactions
with neonicotinoids. Yet the interactions with Tyr185
contribute to the afﬁnity for neonicotinoids. The stacking
level for CTD appears to be weaker than that for IMI
(Fig. 4a, b). In addition, the stacking interaction resulted in
CH–p contacts with Trp143 of the methylene (CH2–CH2)
bridge in IMI, which was not seen in CTD, accounting, at
least in part, for the higher binding potency of IMI
(Kd = 1.57 ± 0.21 lM, n = 3) compared to that of CTD
(Kd = 7.26 ± 1.13 lM, n = 3) on the Ls-AChBP as
evaluated by quenching of the protein ﬂuorescence.
Another difference between CTD and IMI is that the
former exposes a hydrogen bond donor NH at position 1,
whereas the latter lacks it. We suggested earlier that this NH
may form a hydrogen bond with the backbone carbonyl of
Trp143 in loop B (Ihara et al. 2007b). As suggested, the NH
of CTD made a hydrogen bond with the backbone carbonyl
of Trp143 from the (+)-chain in the crystal structures of the
Ls-AChBP (Fig. 4b), although it was observed at only 2 of 5
Fig. 4 Imidacloprid (IMI) and clothianidin (CTD) binding to Lym-
naea stagnalis AChBP (Ls-AChBP). a IMI–Ls-AChBP complex. b
CTD–Ls-AChBP complex. The binding site is located at the interface
between two adjacent subunits, as drawn in green for (+)-chains and
in cyan for (-)-chain (see text). The subunits EA and CD interfaces are
shown for the binding sites for IMI (a) and CTD (b), respectively.
Orange broken lines depict hydrogen bonds. In each ligand and amino
acid, chlorine, nitrogen, oxygen and sulfur atoms are colored purple,
blue, red and yellow, respectively
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123interfaces. Such hydrogen bond formation may assist CTD
in keeping contact with nAChRs when large conformational
changes occur in LBD to open the central channel (Mi-
yazawa et al. 2003; Unwin 2005), accounting, at least in
part, for higher agonist efﬁcacy of CTD compared to IMI
and ACh in certain native and recombinant nAChRs
(Brown et al. 2006; Ihara et al. 2004).
Interactions with loop D and selectivity
of neonicotinoids
We have previously shown that substitution of a glutamate
for the glutamine corresponding to Gln55 of Ls-AChBP
(Fig. 1c) markedly reduced the maximum response to IMI
and nitenpyram of the chicken a7 nAChR, whereas muta-
tion of the same glutamine to arginine enhanced it, slightly
shifting the concentration–response curve to the left (lower
concentrations). In complete contrast, the same mutation
reduced the (-)-nicotine sensitivity of the a7, whereas
substitution with a glutamate enhanced it (Shimomura et al.
2002). Therefore, it was postulated that this glutamine
residue is likely to be located in close proximity to the nitro
group of neonicotinoids, and that marked changes in the a7
response to neonicotinoids as well as (-)-nicotine are the
results of electrostatic interactions between the added resi-
dues and the nitro group. Consistent with this hypothesis,
Gln55 faced the nitro groups of IMI and CTD in the crystal
structure of the Ls-AChBP within a hydrogen bondable
distance in the AChBP–IMI complex (\3.3 A ˚ in 2 of 5
interfaces in the crystal structure of the Ls-AChBP)
(Fig. 4). For CTD, however, the distance between the
Gln55 and the nitro group was longer than 3.5 A ˚, excluding
or minimizing a contribution of hydrogen bonding to the
binding potency of CTD.
All vertebrate nAChRs, perhaps apart from those con-
taining either human or rat b4 subunit, are likely to show
reduced sensitivity to neonicotinoids due to the lack of the
basic residues in loop D. The human b4 subunit (Fig. 1c),
as well as rat b4 subunit (sequence not shown), possesses a
lysine as residue corresponding to Gln55 of Ls-AChBP.
However, the vertebrate b4 subunits possess a glutamate
residue as that corresponding to Thr57 in Ls-AChBP which
is located in the vicinity of Gln55 (Fig. 5). This glutamate
residue is postulated to interfere electrostatically with the
neighboring basic residue–neonicotinoid interactions,
thereby reducing the neonicotinoid sensitivity of nAChRs
containing the b4 subunits.
Role of loops C and F in their interactions
with neonicotinoids
We have found that replacement by glutamate of the
proline corresponding to Ser186 in the YXCC motif in
loop C of the Drosophila Da2 subunit reduces the IMI
sensitivity of the Da2b2 hybrid nAChR, whereas its
reverse mutation in the a4b2 nAChR enhanced sensitivity
(Shimomura et al. 2004), suggesting a contribution of the
loop C residue to the neonicotinoid sensitivity of nAC-
hRs. However, another view has been proposed in which
the serine or threonine residue corresponding to Ser186
from (+)-chain of Ls-AChBP in loop C of insect nAChRs
(see Fig. 1c) forms a hydrogen bond with the nitro group
of neonicotinoids, thereby enhancing the binding potency
of neonicotinoids (Tomizawa et al. 2007). In the crystal
structures of Ls-AChBP, Ser186 made hydrogen bonds
with Glu163 and Tyr164 in loop F of (-)-chain but not
with the nitro group of IMI (Fig. 5). This hydrogen bond
web, as well as the basic residues in loop D, seems to
play an important role in determining the neonicotinoid
sensitivity of nAChRs. In most heteromeric vertebrate
nAChRs, a subunits possess acidic residues as those
corresponding to Ser186 in loop C, resulting in electro-
static repulsion of the acidic residues in loop F of b
subunits corresponding to Glu163 in Ls-AChBP (Fig. 1c).
On the other hand, insect nAChR a subunits do not
possess such an acidic residue in loop C (Fig. 1c). Hence,
it is conceivable that amino acids not only from a sub-
units, but also from non-a subunits of insect nAChRs,
contact more effectively with neonicotinoids than those of
vertebrate nAChRs. In this context, Tyr164 may also
contribute indirectly to the neonicotinoid sensitivity of
insect nAChRs because vertebrate non-a subunits possess
phenylalanine residue incapable of assisting the formation
of the hydrogen-bond-network at this position.
Fig. 5 Interactions between loops C, D and F. IMI-binding site of Ls-
AChBP is presented by especially focusing on loops C, D and F. The
binding site at the interface of the subunits C and D is drawn in green
for (+)-chains and in cyan for (-)-chain (see text). In each ligand and
amino acid, chlorine, nitrogen, oxygen and sulfur atoms are colored
purple, blue, red and yellow, respectively. Orange broken lines depict
hydrogen bonds
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123In conclusion, we have for the ﬁrst time elucidated the
crystal structures of the Ls-AChBP in complex with two
commercial neonicotinoids IMI and CTD. Met114 in loop
E and Gln55 in Loop D closest to the nitro group in ne-
onicotinoids, suggesting that corresponding residues in
insect nAChRs may play important roles in determining
neonicotinoid sensitivity. Ser186 in loop C was found to
form hydrogen bonds with Gln163 as well as Tyr164 in
loop F, suggesting that these hydrogen bondable residues
can also indirectly inﬂuence the selective interactions with
neonicotinoids. CTD forms hydrogen bond with the back-
bone carbonyl of Trp143 in loop B and shows weaker
hydrophobic contacts with Trp143 compared with other
neonicotinoids tested, which may altogether lead to its
unique actions on nAChRs. Although there are sequence
and structural similarities between AChBPs and nAChRs,
there are also important differences. Future structural
studies on AChBP mutants engineered to resemble more
closely insect or human nAChRs could help to enhance
even further our understanding of neonicotinoid actions
and selectivity. Nevertheless, we have provided new
insights into the molecular basis of differential actions of
neonicotinoid molecules. These results may be of value in
the design of even safer new crop protection agents.
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